Glenn W. Currier, MD | Psychiatrist.com

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

Original Research

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

August 11, 2025

Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.

Clotilde Guidetti, Stefania Chaikali, Madhukar H. Trivedi, et al

Original Research

Detection and Classification of Suicidal Behavior and Nonsuicidal Self-Injury Behavior in Emergency Departments

October 21, 2015

Glenn W. Currier, Barbara Stanley, Gregory K. Brown, et al

Original Research

Acute Treatment of Psychotic Agitation: A Randomized Comparison of Oral Treatment With Risperidone and Lorazepam Versus Intramuscular Treatment With Haloperidol and Lorazepam

March 1, 2004

Glenn W. Currier, James C-Y Chou, David Feifel, et al

Original Research

Treatment of Comorbid Tuberculosis and Depression

December 1, 2001

Glenn W. Currier, Adam J. Trenton

Original Research

Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation

March 1, 2001

Glenn W. Currier, George M. Simpson

Article

Atypical Antipsychotic Medications in the Psychiatric Emergency Service

December 30, 2000

Glenn W. Currier